Saliva and Dried Blood Spot Therapeutic Drug Monitoring for MDR-TB in Tanzania

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 24, 2019

Primary Completion Date

December 15, 2019

Study Completion Date

December 31, 2019

Conditions

MDR-TB

Interventions

DIAGNOSTIC_TEST

Therapeutic drug monitoring (TDM)

Saliva and dried blood spot samples are collected. Based on the measured drug concentration the dose can be adjusted

Trial Locations (1)

Kibong'oto infectious diseases hospital, Kibong'oto

All Listed Sponsors

collaborator

Kibong'oto Infectious Diseases Hospital

OTHER_GOV

collaborator

University of Virginia

OTHER

lead

Jan-Willem C Alffenaar

OTHER

NCT04124055 - Saliva and Dried Blood Spot Therapeutic Drug Monitoring for MDR-TB in Tanzania | Biotech Hunter | Biotech Hunter